Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 8505 - 8512 of 12011 results
Opioids, FDA and Medicare Advantage Spending on the List for Congress
February 24, 2016| Blog| Viewpoint
Mintz Receives M&A Advisor’s Restructuring Community Impact Award
February 23, 2016| Blog| Viewpoint
Congress to Continue Work on Energy Issues Amid Supreme Court Uncertainty
February 23, 2016| Blog| Viewpoint
Ransomware Strikes California Hospital - Could You Be Next?
February 23, 2016| Blog| Viewpoint
Groundbreaking Multi-Payer Alignment on Core Measures for Quality-Based Payments
February 23, 2016| Blog| Viewpoint
Provider Confusion and Interoperability Concerns Prompt OCR and ONC to Release Guidance on PHI Sharing
February 22, 2016| Blog| Viewpoint
Preemption Defense in the Ninth Circuit Is “Not Dead Yet”
February 19, 2016| Blog| Viewpoint
Health Care: What's on the Radar for This Congressional Work Period
February 19, 2016| Advisory| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|